Package 0591-0345-05

{"route": ["ORAL"], "spl_id": "98d6e01a-d15c-47b4-82ae-87705e8ed7a9", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666", "897683", "897722"], "spl_set_id": ["a0343397-897b-46d6-943f-a87e07e1de10"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0345-01)", "package_ndc": "0591-0345-01", "marketing_start_date": "19861001"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0345-05)", "package_ndc": "0591-0345-05", "marketing_start_date": "19861001"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0345-10)", "package_ndc": "0591-0345-10", "marketing_start_date": "19861001"}], "brand_name": "Verapamil Hydrochloride", "product_id": "0591-0345_98d6e01a-d15c-47b4-82ae-87705e8ed7a9", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0591-0345", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA070994", "marketing_category": "ANDA", "marketing_start_date": "19861001", "listing_expiration_date": "20261231"}